Jeena Sikho Lifecare Limited (JSLL) — Announcement | 9 August 2026

· NSE Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
JSLL files investor presentation for Q1FY27 results ahead of earnings call
🔄 What Changed
Revenue grew 29% YoY to ₹22,440 lakhs; EBITDA rose 17% YoY to ₹9,211 lakhs; EBITDA margin expanded to 41%
🔮 What's Next
Management indicated plans for ultra-luxury wellness resorts and expansion of hospital network
💡 Investor Takeaway
JSLL is scaling its high-margin integrated Ayurveda model with strong growth in both services and product segments.

Jeena Sikho Lifecare Limited (JSLL) presented its Q1FY27 investor deck on August 9, 2026, ahead of its August 10 earnings call, showcasing robust growth in integrated Ayurveda healthcare. Revenue surged 29% YoY to ₹22,440 lakhs, driven by 41% EBITDA margin expansion and a 17% YoY rise in EBITDA to ₹9,211 lakhs. The company operates 62 hospitals across 23 states with 2,400 beds, contributing to 51 NABH-accredited facilities and a 53% product revenue share from its 330+ Ayurvedic SKUs. Key growth levers include clinic network expansion, cross-selling between services and products, and asset-light franchise model. Management highlighted strong patient conversion from health camps generating ~₹60 lakhs per event in Meerut. The filing underscores JSLL's position as India's fastest-growing Ayurveda healthcare player with scalable operations and high-margin recurring revenue streams.

📄 View Original Announcement (PDF)

About Jeena Sikho Lifecare Limited (JSLL)

Healthcare · Pharmaceuticals · Listed on NSE

Market Cap: ₹6,347.42 Cr P/E: 26.9 ROE: 187.8% ROCE: 261.5% Div Yield: 0.88%

View full JSLL stock details →

📡 Get AI alerts when JSLL files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track JSLL — Free

📊 More JSLL filings

See all JSLL filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when JSLL files new disclosures

Track JSLL filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track JSLL — Free

Free account · 2 AI queries/day